Back to 
Jacobs Levy Equity Management, Inc.
Jacobs Levy Equity Management, Inc.
VKTX
Showing 0 of 2 quarters
Position history for Jacobs Levy Equity Management, Inc.'s holdings in Viking Therapeutics, Inc.
No. Jacobs Levy Equity Management exited its VKTX (Viking Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 487,313 shares worth $1.3M. Jacobs Levy Equity Management first reported VKTX in Q3 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.